Chemoinformaics analysis of 3,8-dihydroxy-10-methoxy-9-[(E)-3-methylbut-1-enyl]-6-(2-methylprop-1-enyl)-6H-chromeno[4,3-b]chromen-7-one
Molecular Weight | 434.488 | nRot | 4 |
Heavy Atom Molecular Weight | 408.28 | nRig | 7 |
Exact Molecular Weight | 434.173 | nRing | 4 |
Solubility: LogS | -3.271 | nHRing | 2 |
Solubility: LogP | 3.022 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
nHA | 6 | APOL | 65.5686 |
nHD | 2 | BPOL | 32.1594 |
QED | 0.659 |
Synth | 1.798 |
Natural Product Likeliness | 0.173 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.01 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.37 |
MDCK | 0.0000244 |
BBB | 0.672 |
PPB | 0.920469 |
VDSS | 1.091 |
FU | 0.0395428 |
CYP1A2-inh | 0.968 |
CYP1A2-sub | 0.957 |
CYP2c19-inh | 0.916 |
CYP2c19-sub | 0.883 |
CYP2c9-inh | 0.213 |
CYP2c9-sub | 0.889 |
CYP2d6-inh | 0.814 |
CYP2d6-sub | 0.943 |
CYP3a4-inh | 0.632 |
CYP3a4-sub | 0.449 |
CL | 11.272 |
T12 | 0.67 |
hERG | 0.04 |
Ames | 0.135 |
ROA | 0.028 |
SkinSen | 0.805 |
Carcinogencity | 0.789 |
EI | 0.973 |
Respiratory | 0.084 |
NR-Aromatase | 0.017 |
Antiviral | Yes |
Prediction | 0.781867 |